Clinical trial
A PhaseⅠFood-Effect Study of Hemay022 in Healthy Subjects
NCT04673474 is registered in ClinicalTrials.gov with Tianjin Hemay Oncology Pharmaceutical Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A PhaseⅠFood-Effect Study of Hemay022 in Healthy Subjects
- Lead sponsor
- Tianjin Hemay Oncology Pharmaceutical Co., Ltd
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- December 9, 2020
- Completion date
- May 31, 2021
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
food-drug interaction